Heterologous Regulation of Mu-opioid (MOP) Receptor Mobility in the Membrane of SH-SY5Y Cells

Overview

Journal J Biol Chem

Specialty Biochemistry

Date 2014 Sep 4

PMID 25183007

Citations 7

Authors

Kevin Carayon

Lionel Mouledous

Anne Combedazou

Serge Mazeres

Evert Haanappel

Laurence Salome

Catherine Mollereau

Affiliations

Soon will be listed here.

Abstract

The dynamic organization of G protein-coupled receptors in the plasma membrane is suspected of playing a role in their function. The regulation of the diffusion mode of the mu-opioid (MOP) receptor was previously shown to be agonist-specific. Here we investigate the regulation of MOP receptor diffusion by heterologous activation of other G protein-coupled receptors and characterize the dynamic properties of the MOP receptor within the heterodimer MOP/neuropeptide FF (NPFF2) receptor. The data show that the dynamics and signaling of the MOP receptor in SH-SY5Y cells are modified by the activation of α2-adrenergic and NPFF2 receptors, but not by the activation of receptors not described to interact with the opioid receptor. By combining, for the first time, fluorescence recovery after photobleaching at variable radius experiments with bimolecular fluorescence complementation, we show that the MOP/NPFF2 heterodimer adopts a specific diffusion behavior that corresponds to a mix of the dynamic properties of both MOP and NPFF2 receptors. Altogether, the data suggest that heterologous regulation is accompanied by a specific organization of receptors in the membrane.

Citing Articles

Luminescence- and Fluorescence-Based Complementation Assays to Screen for GPCR Oligomerization: Current State of the Art.

Wouters E, Vasudevan L, Crans R, Saini D, Stove C Int J Mol Sci. 2019; 20(12).

PMID: 31213021 PMC: 6627893. DOI: 10.3390/ijms20122958.

Temporal dependence of shifts in mu opioid receptor mobility at the cell surface after agonist binding observed by single-particle tracking.

Metz M, Pennock R, Krapf D, Hentges S Sci Rep. 2019; 9(1):7297.

PMID: 31086197 PMC: 6514008. DOI: 10.1038/s41598-019-43657-x.

GFP fluorescence: A few lesser-known nuggets that make it work.

Sarkar P, Chattopadhyay A J Biosci. 2018; 43(3):421-430.

PMID: 30002261

Dynamic lateral organization of opioid receptors (kappa, mu and mu ) in the plasma membrane at the nanoscale level.

Rogacki M, Golfetto O, Tobin S, Li T, Biswas S, Jorand R Traffic. 2018; .

PMID: 29808515 PMC: 6120469. DOI: 10.1111/tra.12582.

Methods used to study the oligomeric structure of G-protein-coupled receptors.

Guo H, An S, Ward R, Yang Y, Liu Y, Guo X Biosci Rep. 2017; 37(2).

PMID: 28062602 PMC: 5398257. DOI: 10.1042/BSR20160547.

References

Chabot-Dore A, Schuster D, Stone L, Wilcox G . Analgesic synergy between opioid and α2 -adrenoceptors. Br J Pharmacol. 2014; 172(2):388-402. PMC: 4292955. DOI: 10.1111/bph.12695. View

Berglund M, Schober D, Esterman M, Gehlert D . Neuropeptide Y Y4 receptor homodimers dissociate upon agonist stimulation. J Pharmacol Exp Ther. 2003; 307(3):1120-6. DOI: 10.1124/jpet.103.055673. View

Calizo R, Scarlata S . Discrepancy between fluorescence correlation spectroscopy and fluorescence recovery after photobleaching diffusion measurements of G-protein-coupled receptors. Anal Biochem. 2013; 440(1):40-8. PMC: 3770895. DOI: 10.1016/j.ab.2013.04.033. View

Mollereau C, Mazarguil H, Zajac J, Roumy M . Neuropeptide FF (NPFF) analogs functionally antagonize opioid activities in NPFF2 receptor-transfected SH-SY5Y neuroblastoma cells. Mol Pharmacol. 2004; 67(3):965-75. DOI: 10.1124/mol.104.004614. View

Rozenfeld R, Devi L . Receptor heteromerization and drug discovery. Trends Pharmacol Sci. 2010; 31(3):124-30. PMC: 2834828. DOI: 10.1016/j.tips.2009.11.008. View

Harrison L, Kastin A, Zadina J . Opiate tolerance and dependence: receptors, G-proteins, and antiopiates. Peptides. 1998; 19(9):1603-30. DOI: 10.1016/s0196-9781(98)00126-0. View

Soumpasis D . Theoretical analysis of fluorescence photobleaching recovery experiments. Biophys J. 1983; 41(1):95-7. PMC: 1329018. DOI: 10.1016/S0006-3495(83)84410-5. View

Dupouy V, Zajac J . Neuropeptide FF receptors control morphine-induced analgesia in the parafascicular nucleus and the dorsal raphe nucleus. Eur J Pharmacol. 1997; 330(2-3):129-37. DOI: 10.1016/s0014-2999(97)01017-0. View

Salome L, Cazeils J, Lopez A, Tocanne J . Characterization of membrane domains by FRAP experiments at variable observation areas. Eur Biophys J. 1998; 27(4):391-402. DOI: 10.1007/s002490050146. View

10.

Pfeiffer M, Koch T, Schroder H, Laugsch M, Hollt V, Schulz S . Heterodimerization of somatostatin and opioid receptors cross-modulates phosphorylation, internalization, and desensitization. J Biol Chem. 2002; 277(22):19762-72. DOI: 10.1074/jbc.M110373200. View

11.

Roumy M, Lorenzo C, Mazeres S, Bouchet S, Zajac J, Mollereau C . Physical association between neuropeptide FF and micro-opioid receptors as a possible molecular basis for anti-opioid activity. J Biol Chem. 2007; 282(11):8332-42. DOI: 10.1074/jbc.M606946200. View

12.

Mouledous L, Frances B, Zajac J . Modulation of basal and morphine-induced neuronal activity by a NPFF(2) selective agonist measured by c-Fos mapping of the mouse brain. Synapse. 2010; 64(9):672-81. DOI: 10.1002/syn.20774. View

13.

Pfeiffer M, Kirscht S, Stumm R, Koch T, Wu D, Laugsch M . Heterodimerization of substance P and mu-opioid receptors regulates receptor trafficking and resensitization. J Biol Chem. 2003; 278(51):51630-7. DOI: 10.1074/jbc.M307095200. View

14.

Sauliere A, Gaibelet G, Millot C, Mazeres S, Lopez A, Salome L . Diffusion of the mu opioid receptor at the surface of human neuroblastoma SH-SY5Y cells is restricted to permeable domains. FEBS Lett. 2006; 580(22):5227-31. DOI: 10.1016/j.febslet.2006.08.056. View

15.

Kasai R, Suzuki K, Prossnitz E, Koyama-Honda I, Nakada C, Fujiwara T . Full characterization of GPCR monomer-dimer dynamic equilibrium by single molecule imaging. J Cell Biol. 2011; 192(3):463-80. PMC: 3101103. DOI: 10.1083/jcb.201009128. View

16.

Pucadyil T, Kalipatnapu S, Harikumar K, Rangaraj N, Karnik S, Chattopadhyay A . G-protein-dependent cell surface dynamics of the human serotonin1A receptor tagged to yellow fluorescent protein. Biochemistry. 2004; 43(50):15852-62. DOI: 10.1021/bi0480887. View

17.

Vilardaga J, Agnati L, Fuxe K, Ciruela F . G-protein-coupled receptor heteromer dynamics. J Cell Sci. 2010; 123(Pt 24):4215-20. PMC: 2995613. DOI: 10.1242/jcs.063354. View

18.

Qiu Y, Wang Y, Law P, Chen H, Loh H . Cholesterol regulates micro-opioid receptor-induced beta-arrestin 2 translocation to membrane lipid rafts. Mol Pharmacol. 2011; 80(1):210-8. PMC: 3127540. DOI: 10.1124/mol.110.070870. View

19.

Vaughan P, Peers C, Walker J . The use of the human neuroblastoma SH-SY5Y to study the effect of second messengers on noradrenaline release. Gen Pharmacol. 1995; 26(6):1191-201. DOI: 10.1016/0306-3623(94)00312-b. View

20.

Williams J, Ingram S, Henderson G, Chavkin C, Von Zastrow M, Schulz S . Regulation of μ-opioid receptors: desensitization, phosphorylation, internalization, and tolerance. Pharmacol Rev. 2013; 65(1):223-54. PMC: 3565916. DOI: 10.1124/pr.112.005942. View